While a few previous case reports have also reported elevations in CK-MB and CK-B subunit in the sera of patients with neuromuscular diseases including ALS [10,11], again presumably reflecting neuromuscular involvement, a role of CK-MB as a biomarker for ALS has never been formally explored. Here, CKB is linked to amyotrophic lateral sclerosis.